IMMUNOTHERAPY BRIDGE
December 1st-2nd, 2021

PRESIDENTS

Ascerto

Paolo A. Ascierto

Director, Medical Oncology, Melanoma, Cancer Immunotherapy and Development Therapeutics Department, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Bernard Fox

Bernard A. Fox

Chief of Molecular and Tumor Immunology Laboratory, Robert W. Franz Cancer Research Center – Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, US

Patrick Hwu

Patrick Hwu

President & CEO, Moffitt Cancer Center, Tampa, FL, US

puzanov

Igor Puzanov

Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, NY, US

SCIENTIFIC BOARD

agarwala

Sanjiv Agarwala

Professor & Chief, Haematology & Oncology, St Luke’s University Hospital and Temple University, Bethlehem, PA, US

Ascerto

Paolo A. Ascierto

Director, Medical Oncology, Melanoma, Cancer Immunotherapy and Development Therapeutics Department, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

carlo Bifulco

Carlo Bifulco

Medical Director of Oncological Molecular Pathology and Pathology Informatics, Providence Oregon Regional Laboratory and Earle A. Chiles Research Institute, Portland, OR, US

Elizabeth-Burton

Elizabeth Burton

Director, Melanoma Research Planning & Development, The University of Texas MD Anderson Cancer Center, Houston, TX, US

butterfield

Lisa H. Butterfield

Adjunct Professor, Microbiology and Immunology, UCSF, VP, PICI Research & Development, Parker Institute for Cancer Immunotherapy, San Francisco, CA, US

corrado caraco

Corrado Caracò

Director of Melanoma and Skin Tumor Surgery, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Demaria

Sandra Demaria

Professor of Pathology and Laboratory Medicine, Professor of Radiation Oncology and Adjunct Professor at Department of Pathology, Weill Cornell Medical College and NYU School of Medicine, New York City, NY, US

dummer

Reinhard Dummer

Professor of Dermatology, University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland

Bernard Fox

Bernard A. Fox

Chief of Molecular and Tumor Immunology Laboratory, Robert W. Franz Cancer Research Center – Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, US

Jerome galone

Jerome Galon

INSERM Laboratory of Integrative Cancer Immunology, Team labeled League Against Cancer; Cordeliers Research Center, Sorbonne University, University of Paris, Paris, France

garbe

Claus Garbe

University Professor of Dermatology, Division of Dermatologic Oncology Department of Dermatology, Eberhard- Karls University Tuebingen, Germany

Hamid

Omid Hamid

Chief of Research/ Immuno-Oncology and Co-Director, Cutaneous Malignancy Program, The Angeles Clinic and Research Institute, Los Angeles, CA, USA

Patrick Hwu

Patrick Hwu

Patrick Hwu, MD, President & CEO, Moffitt Cancer Center, Tampa, FL, US

masucci

Giuseppe Masucci

M.D., Associate Professor, Department of Oncology-Pathology and KcRN, Karolinska Institutet, Cancer Centrum Karolinska (CCK), Karolinska University Hospital, Stockholm, Sweden

Giuseppe Palmieri

Giuseppe Palmieri

President Italian Melanoma Intergroup (IMI), Head of Unit of Cancer Genetics, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Sassari, Italy

Iman-Osman

Iman Osman

Rudolf L. Baer MD Professor of Dermatology, Professor, Departments of Medicine (Oncology) and Urology, Director, Interdisciplinary Melanoma Program, Associate Dean for Translational Research Support, New York University Langone, Medical School, New York, NY, US

postow

Michael Postow

Memorial Sloan Kettering Cancer Center, New York, NY, US

puzanov

Igor Puzanov

Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, NY, US

thurin

Magdalena Thurin

Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, US

withington

Tara Withington

Executive Director of Society of Immunotherapy for Cancer (SITC), Milwaukee, WI, USA